NICE refuses to approve Lucentis for Diabetic Macular Oedema. 26/07/11

Listen in pop-out player

We look at the impact of NICE's decision not to approve a drug used for treating diabetic macular oedema, a condition affecting 50 000 people in the UK. Plus more from Sight Vilage, the exhibition which showcases the latest technology for blind and partially sighted people.

Release date:

Available now

20 minutes

Last on

Tue 26 Jul 2011 20:40